Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease.

作者: Colin R Dunstan , Dieter Felsenberg , Markus J Seibel

DOI: 10.1038/NCPONC0688

关键词: Side effectBone diseaseIntensive care medicineOsteoporosisBisphosphonateOsteonecrosis of the jawAdverse effectBone metastasisBreast cancerMedicine

摘要: Bisphosphonates are used for skeletal protection in osteoporosis, cancer bone metastasis, multiple myeloma, and Paget's disease of the bone; however, these drugs also have potential causing a number adverse effects. While do not limit bisphosphonate use, incidence events can be minimized if appropriate care is taken with their administration, by maintaining surveillance patient care, as discussed this review. valuable class potent anti-resorptive actions that make them ideal bone. It has become apparent, to cause care. We review range reactions therapy particular emphasis on recently identified association between long-term treatment osteonecrosis jaw. This potentially serious side effect seen mostly patients myeloma or breast metastases who receive intravenous treatment. etiology uncertain, strong dental pathology interventions highlights need close attention health group.

参考文章(104)
MICHAEL R. MARKIEWICZ, JOSEPH E. MARGARONE, JOHN H. CAMPBELL, ALFREDO AGUIRRE, Bisphosphonate-associated osteonecrosis of the jaws: A review of current knowledge Journal of the American Dental Association. ,vol. 136, pp. 1669- 1674 ,(2005) , 10.14219/JADA.ARCHIVE.2005.0109
S. Hoefert, H. Eufinger, Kieferknochennekrosen als mögliche unerwünschte Wirkung von Bisphosphonaten Mund-, Kiefer- Und Gesichtschirurgie. ,vol. 9, pp. 233- 238 ,(2005) , 10.1007/S10006-005-0624-6
Christophe Champallou, Jean-Pierre Basuyau, Corine Veyret, Paule Chinet, Marc Debled, Annie Chevrier, Marie-Hélène Grongnet, Philippe Brunelle, Hypocalcemia Following Pamidronate Administration for Bone Metastases of Solid Tumor: Three Clinical Case Reports Journal of Pain and Symptom Management. ,vol. 25, pp. 185- 190 ,(2003) , 10.1016/S0885-3924(02)00644-9
Lenard M. Lichtenberger, Jimmy J. Romero, George W. Gibson, Marion A. Blank, Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa. Digestive Diseases and Sciences. ,vol. 45, pp. 1792- 1801 ,(2000) , 10.1023/A:1005574009856
Osteonecrosis of the jaw and bisphosphonates. The New England Journal of Medicine. ,vol. 353, pp. 99- 102 ,(2005) , 10.1056/NEJM200507073530120
Nicole Barbara Vogt-ferrier, Michel Willy Richter, Jean-Pierre Carrel, Alain Junod, Ostéonécrose des maxillaires et bisphosphonates. Revue médicale suisse. ,vol. 1, pp. 2537- 2543 ,(2005)
Patrick M Purcell, Ian W Boyd, Bisphosphonates and osteonecrosis of the jaw. The Medical Journal of Australia. ,vol. 182, pp. 417- 418 ,(2005) , 10.5694/J.1326-5377.2005.TB06762.X
J. Garatea Crelgo, Daniel Pastor Zuazaga, Raúl Martino Gorbea, Amaya Etayo Pérez, C. Sebastián López, Osteonecrosis maxilar y bisfosfonatos: presentación de tres nuevos casos Medicina Oral Patologia Oral Y Cirugia Bucal. ,vol. 11, pp. 76- 79 ,(2006)
J.-Y. Reginster, H. W. Minne, O. H. Sorensen, M. Hooper, C. Roux, M. L. Brandi, B. Lund, D. Ethgen, S. Pack, I. Roumagnac, R. Eastell, Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Osteoporosis International. ,vol. 11, pp. 83- 91 ,(2000) , 10.1007/S001980050010